158 related articles for article (PubMed ID: 9729531)
1. Human immunodeficiency virus type 1-like DNA sequences and immunoreactive viral particles with unique association with breast cancer.
Rakowicz-Szulczynska EM; Jackson B; Szulczynska AM; Smith M
Clin Diagn Lab Immunol; 1998 Sep; 5(5):645-53. PubMed ID: 9729531
[TBL] [Abstract][Full Text] [Related]
2. Prostate, breast and gynecological cancer markers RAK with homology to HIV-1.
Rakowicz-Szulczynska EM; Jackson B; Snyder W
Cancer Lett; 1998 Feb; 124(2):213-23. PubMed ID: 9500213
[TBL] [Abstract][Full Text] [Related]
3. Relevance of the viral RAK alpha gene in diagnosis of malignant versus nonmalignant tumors of the ovary and uterus.
Rakowicz-Szulczynska EM
Clin Diagn Lab Immunol; 2000 May; 7(3):360-5. PubMed ID: 10799446
[TBL] [Abstract][Full Text] [Related]
4. Giant syncytia and virus-like particles in ovarian carcinoma cells isolated from ascites fluid.
Rakowicz-Szulczynska EM; McIntosh DG; Smith ML
Clin Diagn Lab Immunol; 1999 Jan; 6(1):115-26. PubMed ID: 9874674
[TBL] [Abstract][Full Text] [Related]
5. Inactivation of a common epitope responsible for the induction of antibody-dependent enhancement of HIV.
Mitchell WM; Ding L; Gabriel J
AIDS; 1998 Jan; 12(2):147-56. PubMed ID: 9468363
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical versus molecular detection of RAK antigens in breast cancer.
Kyriacou KC; Iacovou F; Adamou A; Hadjisavvas A; Rakowicz-Szulczynska EM
Exp Mol Pathol; 2000 Aug; 69(1):27-36. PubMed ID: 10891290
[TBL] [Abstract][Full Text] [Related]
7. Improbability of harmful autoimmune responses resulting from immunization with HIV-1 envelope glycoproteins.
Neurath AR; Strick N; Li YY; Jiang S
AIDS Res Hum Retroviruses; 1993 Dec; 9(12):1195-208. PubMed ID: 8142138
[TBL] [Abstract][Full Text] [Related]
8. Envelope sequence variability and serologic characterization of HIV type 1 group O isolates from equatorial guinea.
Hunt JC; Golden AM; Lund JK; Gürtler LG; Zekeng L; Obiang J; Kaptué L; Hampl H; Vallari A; Devare SG
AIDS Res Hum Retroviruses; 1997 Aug; 13(12):995-1005. PubMed ID: 9264286
[TBL] [Abstract][Full Text] [Related]
9. Mutations in both gp120 and gp41 are responsible for the broad neutralization resistance of variant human immunodeficiency virus type 1 MN to antibodies directed at V3 and non-V3 epitopes.
Park EJ; Vujcic LK; Anand R; Theodore TS; Quinnan GV
J Virol; 1998 Sep; 72(9):7099-107. PubMed ID: 9696803
[TBL] [Abstract][Full Text] [Related]
10. Molecular cloning and analysis of functional envelope genes from human immunodeficiency virus type 1 sequence subtypes A through G. The WHO and NIAID Networks for HIV Isolation and Characterization.
Gao F; Morrison SG; Robertson DL; Thornton CL; Craig S; Karlsson G; Sodroski J; Morgado M; Galvao-Castro B; von Briesen H; Beddows S; Weber J; Sharp PM; Shaw GM; Hahn BH
J Virol; 1996 Mar; 70(3):1651-67. PubMed ID: 8627686
[TBL] [Abstract][Full Text] [Related]
11. Secretory anti-human immunodeficiency virus (HIV) antibodies in colostrum and breast milk are not a major determinant of the protection of early postnatal transmission of HIV.
Becquart P; Hocini H; Lévy M; Sépou A; Kazatchkine MD; Bélec L
J Infect Dis; 2000 Feb; 181(2):532-9. PubMed ID: 10669336
[TBL] [Abstract][Full Text] [Related]
12. Selection of human anti-human immunodeficiency virus type 1 envelope single-chain antibodies from a peripheral blood cell-based phage repertoire.
de Haard JJ; Kazemier B; Oudshoorn P; Boender P; van Gemen B; Koolen MJ; van der Groen G; Hoogenboom HR; Arends JW
J Gen Virol; 1998 Dec; 79 ( Pt 12)():2883-94. PubMed ID: 9880001
[TBL] [Abstract][Full Text] [Related]
13. Sequence analysis of selected regions of the env (V3 loop and gp41) and gag (p7) reading frames of Ethiopian human immunodeficiency virus type 1 strains.
Ayehunie S; Johansson B; Sönnerborg A; Zewdie DW; Britton S; Strannegård O
Arch Virol; 1993; 128(3-4):229-39. PubMed ID: 8435043
[TBL] [Abstract][Full Text] [Related]
14. Characterization of stable, soluble trimers containing complete ectodomains of human immunodeficiency virus type 1 envelope glycoproteins.
Yang X; Farzan M; Wyatt R; Sodroski J
J Virol; 2000 Jun; 74(12):5716-25. PubMed ID: 10823881
[TBL] [Abstract][Full Text] [Related]
15. Mutations in human immunodeficiency virus type 1 gp41 affect sensitivity to neutralization by gp120 antibodies.
Back NK; Smit L; Schutten M; Nara PL; Tersmette M; Goudsmit J
J Virol; 1993 Nov; 67(11):6897-902. PubMed ID: 8411395
[TBL] [Abstract][Full Text] [Related]
16. N-linked glycosylation of the V3 loop and the immunologically silent face of gp120 protects human immunodeficiency virus type 1 SF162 from neutralization by anti-gp120 and anti-gp41 antibodies.
McCaffrey RA; Saunders C; Hensel M; Stamatatos L
J Virol; 2004 Apr; 78(7):3279-95. PubMed ID: 15016849
[TBL] [Abstract][Full Text] [Related]
17. Changes in both gp120 and gp41 can account for increased growth potential and expanded host range of human immunodeficiency virus type 1.
Fujita K; Silver J; Peden K
J Virol; 1992 Jul; 66(7):4445-51. PubMed ID: 1602552
[TBL] [Abstract][Full Text] [Related]
18. Antigenic properties of the HIV envelope on virions in solution.
Ray K; Mengistu M; Yu L; Lewis GK; Lakowicz JR; DeVico AL
J Virol; 2014 Feb; 88(3):1795-808. PubMed ID: 24284318
[TBL] [Abstract][Full Text] [Related]
19. Variability of human immunodeficiency virus type 2 (hiv-2) infecting patients living in france.
Damond F; Apetrei C; Robertson DL; Souquière S; Leprêtre A; Matheron S; Plantier JC; Brun-Vézinet F; Simon F
Virology; 2001 Feb; 280(1):19-30. PubMed ID: 11162815
[TBL] [Abstract][Full Text] [Related]
20. Compartmentalization of the IgG immune response to HIV-1 in breast milk.
Becquart P; Hocini H; Garin B; Sépou A; Kazatchkine MD; Bélec L
AIDS; 1999 Jul; 13(11):1323-31. PubMed ID: 10449284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
